Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Results of an educational program to promote the use of pooled instead of single-donor platelet transfusions.

Burch M, Schneider R, Barakat A, Abushahin L, Cao Y, Ewing J, Stone MJ.

Proc (Bayl Univ Med Cent). 2013 Jan;26(1):3-5.

2.

Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.

Xiao W, Tormey CA, Capetillo A, Maitta RW.

Vox Sang. 2013 Nov;105(4):334-40. doi: 10.1111/vox.12063. Epub 2013 Jun 27.

PMID:
23802769
3.

Canine platelet alloimmunization: the role of donor selection.

Slichter SJ, O'Donnell MR, Weiden PL, Storb R, Schroeder ML.

Br J Haematol. 1986 Aug;63(4):713-27.

PMID:
3730294
4.

High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure.

Kelley DL, Fegan RL, Ng AT, Kennedy MK, Blanda E, Chambers LA, Kennedy MS, Lasky LC.

Transfusion. 1997 May;37(5):482-6.

PMID:
9149771
5.

The use of PEG-rhuMGDF in platelet apheresis.

Kuter DJ.

Stem Cells. 1998;16 Suppl 2:231-42. Review.

6.

Clinical and laboratory factors underlying refractoriness to platelet transfusions.

Friedberg RC.

J Clin Apher. 1996;11(3):143-8. Review.

PMID:
8915819
7.

Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.

Hux BD, Martin LG.

J Vet Emerg Crit Care (San Antonio). 2012 Feb;22(1):73-80. doi: 10.1111/j.1476-4431.2011.00706.x. Review.

PMID:
23016744
8.

Current status of leukocyte and platelet administration in cancer therapy.

Walker EM Jr, Cannon A, Mitchum EN.

Ann Clin Lab Sci. 1983 Nov-Dec;13(6):453-73. Review.

PMID:
6197928
9.

Febrile reactions after platelet transfusion: the effect of single versus multiple donors.

Chambers LA, Kruskall MS, Pacini DG, Donovan LM.

Transfusion. 1990 Mar-Apr;30(3):219-21.

PMID:
1967118
10.

Single donor platelets: can we afford to use them? Can we afford not to use them?

Zeger G, Williams CT, Shulman IA.

Transfus Sci. 1997 Dec;18(4):585-8. Review.

PMID:
10178683
11.

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.

Gurkan E, Patah PA, Saliba RM, Ramos CA, Anderson BS, Champlin R, de Lima M, Lichtiger B.

Bone Marrow Transplant. 2007 Sep;40(5):461-4. Epub 2007 Jun 25.

PMID:
17589530
12.

Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.

Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG.

Transfusion. 1995 Aug;35(8):645-52.

PMID:
7631404
14.

The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.

Kelley DL, Mangini J, Lopez-Plaza I, Triulzi DJ.

Transfusion. 2000 Apr;40(4):439-42.

PMID:
10773056
15.

A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.

Messerschmidt GL, Makuch R, Appelbaum F, Ungerleider RS, Abrams R, O'Donnell J, Holohan TV, Fontana J, Wright D, Anagnou NP, et al.

Cancer. 1988 Aug 15;62(4):795-801.

16.

Platelet transfusion. Current techniques, remaining problems, and future prospects.

Herman JH, Kamel HT.

Am J Pediatr Hematol Oncol. 1987 Fall;9(3):272-86. Review.

PMID:
3314551
17.

Posttransfusion purpura following bone marrow transplantation.

Evenson DA, Stroncek DF, Pulkrabek S, Perry EH, Radford J, Miller JS, Verfaillie C.

Transfusion. 1995 Aug;35(8):688-93.

PMID:
7631411
18.

The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets.

Lopez-Plaza I, Weissfeld J, Triulzi DJ.

Transfusion. 1999 Sep;39(9):925-32.

PMID:
10533816
20.

Single donor versus pooled random donor platelet concentrates.

Ness PM, Campbell-Lee SA.

Curr Opin Hematol. 2001 Nov;8(6):392-6. Review.

PMID:
11604581

Supplemental Content

Support Center